ライフサイエンスコーパス: muscimol

1 to 8.9 +/- 0.9 (insulin), then 5.1 +/- 0.5 (muscimol)).

2 used by medial septum (MS) inactivation with muscimol.

3 less of whether its retrieval was blocked by muscimol.

4 imulated motor cortex using the GABA agonist muscimol.

5 lus (predator stress) altered sensitivity to muscimol.

6 icroinfusion of the GABA-A receptor agonist, muscimol.

7 poxide, a benzodiazepine (2.5-5 microg), and muscimol (0.05-5 ng).

8 r (ii) activation of central GABA(A)R by i.c muscimol (0.1 mug/rat).

9 ral injection of the GABA-A receptor agonist muscimol (0.1 nmol in 50 nl).

10 nhibition of neurons in LPBN area (n=6) with muscimol (0.45 nmol per side) reduced dorsal PAG-evoked

11 1.7 g +/- 0.48) by simultaneous infusions of muscimol (0.6 mM/100 nl) into the IRt/PCRt (p < .01).

12 roinjections (100 nl) of the GABA(A) agonist muscimol (1 mm), induced the following: (1) a massive cu

13 cellular fluid, the GABA(A) receptor agonist muscimol (1 nmol/side), or the GABA(A) receptor antagoni

14 reversible inactivation techniques (baclofen/muscimol: 1.0/.1 mmol/L, .3 muL/side).

15 tra-Acb shell infusion of the GABAA agonist, muscimol (10 ng).

16 Incubation of the oocyte with free muscimol (100 microM-5 mM), PEG-muscimol (500 microM), o

17 ent by D1 (SKF38393; 100ng/side) or GABA(A) (muscimol; 100ng/side) receptor agonists in ovariectomize

18 , ethanol (up to 50 mM) did not affect [(3)H]muscimol (15 nM) binding to the immunoprecipitated delta

19 Microinjection of the GABA agonist muscimol (250 pmol) into the caudal ventrolateral periaq

20 Ethanol (1-50 mM) neither affected [(3)H]muscimol (3 nM) binding nor diazepam-insensitive [(3)H]R

21 Importantly, SI mice responded to muscimol, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2H

22 te with free muscimol (100 microM-5 mM), PEG-muscimol (500 microM), or GABA (100 microM - 5 mM) subst

23 Phase shifts (mean +/- S.E.M., h) in muscimol/8-OH-DPAT-microinjected hamsters (1.02 +/- 0.30

24 Muscimol (80 pmol), a GABA(A) agonist, or losartan (43.4

25 t 1, hamsters received DRN pretreatment with muscimol (87.6 pmol) or vehicle before DRN 8-OH-DPAT (6

26 ized rats before and after microinjection of muscimol (9 nl; 0.25 mM), a GABA-A receptor agonist, int

27 lonidine (an alpha-2 adrenergic agonist) and muscimol (a GABAa agonist) induce an inhibition of PS.

28 onjugate consisting of approximately 150-200 muscimols (a GABA receptor agonist) covalently joined to

29 Muscimol, a GABA agonist, inactivated part of the OMV, w

30 Muscimol, a GABA agonist, was used to inactivate the pre

31 We injected muscimol, a GABA(A) agonist, and manganese, a magnetic r

32 thyl)-1-hydroxypyrazole (4-AHP) analogues of muscimol, a GABA(A) receptor agonist, has been synthesiz

33 Bilateral injections of muscimol, a GABAA agonist, into the mPFC significantly d

34 us using infusions of fluorophore-conjugated muscimol, a GABAA agonist.

35 receptor subunit gamma2 (TAT-GABAgamma2) and muscimol, a GABAA receptor agonist.

36 The treatment with muscimol, a gamma amino butyric acid receptor-A (GABA(A)

37 esponses by microinjecting artificial CSF or muscimol, a neuronal inhibitor, into the DMH prior to in

38 Low concentrations (0.1-0.3 microm) of muscimol, a selective GABA(A)R agonist, increased the am

39 Injections of muscimol abolished the amplitude increase adaptation of

40 These data point to a presynaptic locus of muscimol action.

41 naptic-type GABA(A) receptors, both THIP and muscimol additionally exhibited, to different degrees, s

42 nd behavioral studies have demonstrated that muscimol administered through the cranial meninges can p

43 However, it has not been proved that muscimol administered via the transmeningeal route can p

44 vation of the primary motor cortex (M1) with muscimol affected anticipatory patterns in S1 and the th

45 Microinjection of muscimol alone modestly decreased baseline HR and MAP bu

46 Muscimol also impaired response control (increased prema

47 Muscimol, an agonist at GABA(A) receptors, produced a la

48 We injected either muscimol, an agonist of GABA, to inactivate the OMV or b

49 Using (3)H-muscimol and (3)H-flunitrazepam we could determine wheth

50 lation the activity of three agonists, GABA, muscimol and 4,5,6,7-tetrahydoisoxazolo[5,4-c]pyridin-3(

51 dorsomedial striatum using the GABA agonists muscimol and baclofen decreased context-induced reinstat

52 In most cases tested, the effects of muscimol and baclofen remained similar when synaptic tra

53 ivation (achieved by presession injection of muscimol and baclofen) in a novel two-reward choice task

54 sponses in NG2 cells, which were mimicked by muscimol and inhibited by bicuculline.

55 GABA and the GABA(A) agonists muscimol and isoguvacine enhanced isolated chloride curr

56 ction time (5CSRT) test, we showed that both muscimol and picrotoxin impaired attention (reduced accu

57 Based on muscimol and tetrodotoxin microinfusions, these glutamat

58 A 50 muL mixture of [(3)H] muscimol and unlabeled muscimol with a final concentrati

59 al circuits using the GABAA receptor agonist muscimol and validated the lesion placement using MRI.

60 /- double knockout, CBS-/+ mice treated with muscimol and wild type (WT) mice.

61 class (e.g., pentobarbital, chloral hydrate, muscimol, and ethanol) produce analgesia and unconscious

62 After injections of either saline or muscimol, animals consumed more of the 0.29 M than the 0

63 bjects, quadrupedal rotations were evoked by muscimol application into SNpr sites that were distinct

64 Muscimol at 5.0mM also prevented seizures, but decreased

65 After injection of muscimol at rostral sites in the dSC, fixation became mo

66 as blocked by inactivation of the mPFCv with muscimol at the time of the initial experience with cont

67 mediate shock; and (2) BLA inactivation with muscimol attenuated the increase in Arc and c-fos mRNA i

68 of the medial prefrontal cortex by baclofen/muscimol (B/M) during testing attenuates renewal when te

69 Additionally, renewal was blocked by muscimol + baclofen injections into LH.

70 Injections of muscimol + baclofen into ventral mPFC in one hemisphere

71 Unilateral injections of muscimol + baclofen into ventral mPFC or SCH 23390 into

72 tivation by GABAA + GABAB receptor agonists (muscimol + baclofen) on this effect.

73 Muscimol+baclofen injections into CeA but not BLA decrea

74 Muscimol+baclofen injections into dmPFC, vmPFC, or OFC d

75 We also assessed the effect of muscimol+baclofen reversible inactivation of vmPFC, dmPF

76 ivated the vSub with GABA receptor agonists (muscimol+baclofen) before the context-induced relapse te

77 CeA or BLA by GABAA+GABAB receptor agonists (muscimol+baclofen, 0.03+0.3 nmol) on cue-induced methamp

78 Conversely, CeA inhibition by muscimol/baclofen microinjections prevented acquisition

79 Interestingly, in CBS-/+ mice treated with muscimol, BBB permeability was significantly decreased c

80 inactivated by infusion of the GABA agonist muscimol before acute stressor exposure.

81 Hippocampal inactivation with muscimol before retention testing disrupted discriminati

82 Females infused with muscimol before stress did not express a deficit in cond

83 Males infused with muscimol before the stressful event did not exhibit faci

84 as bilaterally inactivated with GABA agonist muscimol before the stressor.

85 the effects of single DRN microinjections of muscimol, bicuculline (136 pmol), NMDA, MK-801 (10 pmol)

86 delta-subunit of GABA(A) receptors and [(3)H]muscimol binding to the immunoprecipitated delta-subunit

87 in the rat cerebellum as determined by [(3)H]muscimol binding to the immunoprecipitated receptor asse

88 Inactivation of NRM with muscimol blocked ingestion analgesia during NaCl ingesti

89 application of the GABA(A) receptor agonist muscimol blocked spontaneous correlated increases in int

90 Coapplication of GABA or muscimol, but not of gabazine, with MTSES prevented the

91 we microinfused the GABA-A receptor agonist muscimol (C4H6N2O2; 62.5, 125, 250 ng/side) or antagonis

92 This study provided evidence that muscimol can be delivered via the transmeningeal route i

93 the hypothesis that epidurally administered muscimol can prevent acetylcholine (Ach)-induced focal s

94 fusion of muscimol or fluorophore-conjugated muscimol caused a near complete shift in preference from

95 cells, GABA and the GABA(A) receptor agonist muscimol caused a rapid and transient increase in intrac

96 Muscimol caused a significant increase in wakefulness an

97 Muscimol caused all ipsiversive horizontal saccades from

98 Bath application of GABA or muscimol caused an early hyperpolarization mediated by C

99 It is interesting that 1 microm muscimol caused an inhibition of sIPSCs, which was rever

100 Deactivation of the MnPN with muscimol caused opposite effects.

101 At this muscimol concentration, the average baseline multineuron

102 of cells in the PVT with the GABA(A) agonist muscimol could alter food intake in non-deprived rats.

103 In contrast, muscimol decreased CS synchrony.

104 FC neurons with the GABA agonists baclofen + muscimol decreased cue-induced heroin seeking on withdra

105 ebral infusion of the GABAA receptor agonist muscimol decreased the number of new HVC neurons by 56%.

106 It was proposed that transmeningeal muscimol delivery can be used for the treatment of intra

107 pendent inactivation of either BM or BL with muscimol did not cause a reduction of conditioned freezi

108 ons of the gamma aminobutyric acid-A agonist muscimol did not impair acquisition of the odor discrimi

109 Results showed that (1) [(3)H] muscimol diffused through the meninges into the cortical

110 Muscimol disrupted both retrieval of pups and nursing be

111 esponse to these two distinct stressors, rPH muscimol disrupted habituation to each stressor modality

112 icate that auditory thalamic inactivation by muscimol disrupts acute HPA axis response specifically t

113 In addition, muscimol dose dependently reduced open-field locomotor a

114 GO (2.5 mug) also sensitized intra-Acb shell muscimol-driven feeding.

115 e CE of rabbits (Oryctolagus cuniculus) with muscimol during NMR conditioning and/or during US testin

116 GABA and muscimol each increased MTSEA-Biotin modification of alp

117 evented the effect, suggesting that GABA and muscimol elicit a conformational change that reduces acc

118 Whereas the GABAA receptor agonist muscimol evoked excitatory, inhibitory, or mixed effects

119 However, postsynaptic muscimol-evoked GABA(A) responses remained intact.

120 rized during the preictal phase, whereas the muscimol-evoked GABA(A) reversal potential remained unch

121 ound that 3alpha,5alpha-THP-, SKF38393-, and muscimol-facilitated lordosis was attenuated by infusion

122 Although muscimol failed to change reflex micturition when microi

123 pports the rationale of using transmeningeal muscimol for the treatment of intractable focal neocorti

124 Muscimol (GABA-A agonist) injection in or next to the so

125 biccuculine (GABA-A receptor antagonist) or muscimol (GABA-A receptor agonist) were injected prior t

126 of D-AP5 (glutamate receptor antagonist) and muscimol (GABAA receptor agonist) in the SubC virtually

127 The agonists GABA and muscimol gave EC50 values of 278 mum and 182 mum, respec

128 VN, newborn cells did not survive in the UVN-muscimol group whereas the number of GABAergic pre-exist

129 Consistent with previous studies, muscimol had no effect in EH rats (n = 6), but reduced m

130 Muscimol had no effect in rats with an intact contralate

131 Muscimol has potent antiepileptic efficacy after transme

132 Pu with GABA receptor agonists (baclofen and muscimol) immediately prior to reinstatement testing.

133 Inhibiting activity with the GABA(A) agonist muscimol impaired DMTP.

134 Inactivating CGp with muscimol impaired new learning when rewards were small b

135 These data indicate that transmeningeal muscimol in a submillimolar concentration range can prev

136 sed by DAMGO microinjection and decreased by muscimol in CeA.

137 s and increased the affinity for the agonist muscimol in human alpha1beta2/3gamma2L GABA(A) receptors

138 : inhibition of DLSC attenuated CD evoked by muscimol in SNpr in all four animals.

139 Finally, we used muscimol in the barrel cortex to silence the corticothal

140 PL-IL or OFC infusion with the GABA agonist muscimol in the context of 2 flexible responding tasks:

141 Increasing GABAA transmission with muscimol in the dorsal and ventral mPFC attenuated relap

142 Muscimol in this location also increased the amplitude o

143 l cortex that are differentially affected by muscimol inactivation of medial septum.

144 epresentations in a novel environment during muscimol inactivation of the medial septal area, a manip

145 Muscimol inactivation of the medullary raphe magnus bloc

146 Muscimol inactivation of the PL/IL never impaired switch

147 formal algorithmic behavioral analysis with muscimol inactivation, we provide causal evidence direct

148 ma-aminobutyric acid type A (GABA-A) agonist muscimol increased GSWD occurrence up to 37-fold, wherea

149 Moreover, muscimol increased the frequency but not the amplitude o

150 e gamma-aminobutyric acid A (GABAA) agonist, muscimol, indeed activate locomotion.

151 nt alpha-Ctx, however, could be displaced by muscimol indicating that most of the alpha-Ctx-binding s

152 altering the binding of the GABA agonist [3H]muscimol, indicating that this residue plays a key role

153 Furthermore, similar to U0126, baclofen+muscimol-induced (B+M; 106.8/5.7 ng/0.5 mul/hemisphere)

154 xposure to sweetened fat robustly sensitized muscimol-induced feeding.

155 Furthermore, bilateral muscimol-induced inactivation of the VP abolished the re

156 to restore MAP (n = 5), suggesting that the muscimol-induced reduction of cardiac rhythmic sSNA in D

157 Muscimol infused intra-CA1 before an extinction training

158 r impaired performance, and both saline- and muscimol-infused rats appeared to use immediate task con

159 In kittens, we inactivated motor cortex by muscimol infusion between postnatal weeks 5 and 7.

160 Muscimol infusion into medial septum reduced the probabi

161 strategy switches but not reversals, whereas muscimol infusion into OFC impaired retention of reversa

162 Muscimol infusion into PL-IL impaired retention of strat

163 Muscimol infusion into the medial amygdala decreased fre

164 eral amygdala were then inactivated by local muscimol infusion on day 14.

165 rm retention of the trace eyeblink CR, using muscimol infusion to reversibly inactivate the IP nucleu

166 ally inactivated M1 between weeks 5 and 7 by muscimol infusion.

167 Inactivating the interpositus nucleus with muscimol infusions abolished these conditioned responses

168 In contrast, intra-vmPFC muscimol infusions did not alter the overall intake of c

169 ar surgery and training except they received muscimol infusions immediately before devaluation testin

170 er this treatment would prevent CD evoked by muscimol infusions in SNpr.

171 Muscimol infusions into the AIC diminished intake, total

172 Non-defeated animals receiving muscimol infusions prior to testing with a non-aggressiv

173 ns were necessary for duration judgments, as muscimol infusions produced a specific impairment in ani

174 with striatal gamma activity, and intra-BLA muscimol infusions selectively reduced striatal gamma po

175 ted through amygdala temporary deactivation (muscimol infusions), which rescued the depressive-like b

176 th in vivo electrophysiology, we showed that muscimol inhibited prefrontal firing, whereas picrotoxin

177 Muscimol injection into commissural part of the solitary

178 Muscimol injection into the rostral ventral respiratory

179 Our previous study showed that muscimol injections cause ipsiversive saccades to fall s

180 Intra-MR muscimol injections did not alter the within burst rate

181 itory thalamus was inactivated reversibly by muscimol injections during repeated loud noise exposures

182 In contrast, intra-MR muscimol injections had little effect on the initial lic

183 eted subjects avidly consumed this solution, muscimol injections had no effect either on the volume c

184 Furthermore, after muscimol injections in the LH, the VLPAG/dDpMe contained

185 s near optimally, even after large bilateral muscimol injections into MSTd.

186 approach involving inactivation of the BG by muscimol injections into the caudate nucleus of monkeys

187 We found that muscimol injections into the central PVT dose-dependentl

188 esent experiment investigated the effects of muscimol injections into the rat dorsal anterior cingula

189 ques to characterize the effects of intra-MR muscimol injections on the consumption of either a 0.05

190 gestive behavior, we examined the effects of muscimol injections on the intake of a 3% NaCl solution

191 Muscimol injections produced a significantly larger incr

192 In contrast, in these same animals, muscimol injections significantly increased licking of a

193 in two macaques (Macaca mulatta) with local muscimol injections.

194 ibition of the contralateral intact RTN with muscimol instantly eliminated phrenic nerve discharge (P

195 by infusions of the GABA(A) receptor agonist muscimol into area 13 blocked the devaluation effect: th

196 As expected, injection of Kyn into RVLM or muscimol into commNTS virtually blocked the effect of ca

197 In contrast, infusions of muscimol into Gi had no discernible effect on food intak

198 Microinjections of the GABAA agonist muscimol into PVN inhibit both basal and meningeal-evoke

199 cent area with microinjections of glycine or muscimol into rRPa.

200 were reversibly abolished by an infusion of muscimol into the cerebellar interpositus nucleus.

201 of microinjection of the neuronal inhibitor muscimol into the DMH on increases in HR, MAP and T(co)

202 Microinjecting muscimol into the DMH prior to MDMA prevented increases

203 re virtually abolished by prior injection of muscimol into the DMH.

204 In contrast, microinjection of muscimol into the hypothalamic paraventricular nucleus f

205 To test this, we infused the GABAA agonist muscimol into the IC and the mu-opioid receptor antagoni

206 Infusions of the GABA(A) agonist muscimol into the LS prior to testing significantly incr

207 n that microinjections of the GABA-A agonist muscimol into the median raphe nucleus (MR) result in la

208 rebrospinal fluid control, microinjection of muscimol into the MnPN resulted in significantly higher

209 the gamma-aminobutyric acidA (GABAA) agonist muscimol into the nucleus accumbens shell (AcbSh) induce

210 lso observed food intake after injections of muscimol into the overlying ventricle or laterally adjac

211 Bilateral injection of Kyn or muscimol into the rostral ventral respiratory group (rVR

212 Infusion of the GABAA agonist muscimol into the VM also reduced MCx-SNpr coherence and

213 0 into the accumbens and the GABA(A) agonist muscimol into ventral pallidum (i.e., "disconnection" me

214 mM solutions of a GABA(A) receptor agonist, muscimol, into the MnPN on Fos expression (Fos-IR) in th

215 The results indicate that muscimol joined to qdots via a long-chain PEG linker exh

216 l-PEG-qdots, and the removal of GABA or free muscimol led to a recovery of muscimol-PEG-qdot binding.

217 0 to 198 +/- 24 (insulin), then 133 +/- 23 (muscimol) LSNA gain in % control mmHg-1: from 3.9 +/- 0.

218 Muscimol-mediated excitatory actions were found in a nom

219 Muscimol-mediated inactivation of the vmPFC, and intra-v

220 ability-driven feeding was carried out after muscimol-mediated inactivation of two frontal regions in

221 We unilaterally inactivated M1 by muscimol microinfusion between postnatal weeks 5 and 7 t

222 using unit recordings and inactivation with muscimol microinfusions in rats.

223 he current studies, we used intrahippocampal muscimol microinfusions to transiently inactivate the ma

224 Conversely, inactivation of CeA by muscimol microinjection (0.25 microg) suppressed approac

225 ition of LSr neurons with local baclofen and muscimol microinjection (0.3/0.03 nmol) blocks expressio

226 Muscimol microinjections into a nearby region, the nucle

227 the blood brain permeability; treatment with muscimol mitigated BBB permeability.

228 By contrast, for muscimol, moderate superagonist behaviour was caused by

229 ze, we demonstrated in rats that a bilateral muscimol (MSCI) inactivation (0.70 vs 0.26 and 0 nmol) o

230 Bilateral muscimol (MUS) injections into either the hippocampus or

231 Iontophoresis of the GABAA agonist muscimol (MUS) into the lateral PB extended expiratory d

232 hicle control), the GABA(A) receptor agonist muscimol, muscimol with the GABA(A) receptor antagonist

233 d qdots and PEG-qdots that lacked conjugated muscimol neither exhibited significant binding activity

234 ngle microinjections of bicuculline, but not muscimol, NMDA, or MK-801 induced phase advances.

235 After many switches, however, muscimol no longer impaired performance, and both saline

236 Experiment 3 examined whether the effects of muscimol on aggression were dependent on prior social de

237 o a different class, mimicked the effects of muscimol on sIPSCs: it increased them at low (<or= 0.5 m

238 ural parameters suggested that the effect of muscimol on sucrose intake was not mediated by alteratio

239 h infusion of the GABA agonists baclofen and muscimol, on place acquisition and reversal learning.

240 Systemic muscimol or baclofen are antipruritic against both hista

241 GABA-A and GABA-B receptors, the effects of muscimol or baclofen were studied.

242 thermore, CeA inactivation induced by either muscimol or CRF ASO administration immediately before re

243 or thalamic nuclei (ATN) by microinfusion of muscimol or fluorophore-conjugated muscimol caused a nea

244 etinal activity by intraocular injections of muscimol or gabazine during this period did not alter th

245 exogenously applied GABA(A) receptor agonist muscimol or glycine, either of which under control condi

246 ects of injecting the GABAA receptor agonist muscimol or the GABAA receptor antagonist bicuculline in

247 cular infusions of saline, GABA(A)R agonist (muscimol) or antagonist (gabazine), cell proliferation a

248 nd IL-31Tg mice with combinations of GABA-A (muscimol) or GABA-B (baclofen) receptor agonists 15 to 2

249 diazoxide plus the GABA(A) receptor agonist muscimol, or 5) glybenclamide plus the GABA(A) receptor

250 Rats microinjected with ibotenic acid, muscimol, or a CRF ASO into the CeA before contextual fe

251 Unilateral microinjections of lidocaine, muscimol, or glutamate antagonists into the pTRG inhibit

252 stimuli were neutral, infusion of the GABAA, muscimol, or the NMDA receptor (NMDAR) antagonist ifenpr

253 the application of the high-affinity agonist muscimol partially rescued rapid desensitization compare

254 f GABA or free muscimol led to a recovery of muscimol-PEG-qdot binding.

255 units) and investigated the binding of this muscimol-PEG-qdot conjugate to homomeric rho1 GABAC rece

256 This halo was absent following muscimol-PEG-qdot treatment of oocytes lacking GABAC rec

257 Upon 5- to 10-min incubation with muscimol-PEG-qdots (34 nM in qdot concentration), GABAC-

258 eliminated the fluorescence halo produced by muscimol-PEG-qdots, and the removal of GABA or free musc

259 ity nor diminished the subsequent binding of muscimol-PEG-qdots.

260 Saline and muscimol pretreatment in the concentration range of 0.00

261 information transfer via Te2 inhibition with muscimol prevents any retrieval-evoked neuronal activity

262 inobutyric acid A (GABA(A)) receptor agonist muscimol, prior to a hypoglycemic clamp or under baselin

263 The case is made that muscimol probably caused a hyperexcitation of VTA DA neu

264 combined subthreshold doses of baclofen and muscimol produced a significant synergistic antipruritic

265 rates were significantly suppressed, whereas muscimol raised glucose infusion rates significantly com

266 Muscimol reduced and picrotoxin enhanced bursting and bo

267 Muscimol reduced burst frequency of phrenic nerve activi

268 activation of the CeA with the GABAA agonist muscimol reduced DAMGO (D-Ala2-NMe-Phe4-Glyol5-enkephali

269 In contrast, 0.5-mM muscimol reduced the average EEG Seizure Duration Ratio

270 (2) [(3)H] muscimol-related autoradiography grains were distributed

271 (3) [(3)H] muscimol-related autoradiography grains were localized t

272 In contrast, intra-MD injections of muscimol resulted in a potent dose-dependent suppression

273 ma-aminobutyric acid receptor type A agonist muscimol resulted in an impairment only when BLA was ina

274 and baseline food intake, whereas intra-BLA muscimol selectively blocked only DAMGO-induced food int

275 th bilateral injections of the GABAA agonist muscimol, selectively blocked the expression of SFiA whi

276 g with the obtained SAR indicate that 2a and muscimol share a common binding mode, which deviates fro

277 icantly affect orexin A-induced feeding, but muscimol significantly and dose dependently inhibited or

278 Muscimol significantly increased EEG power in the delta

279 After a 1-hour exposure, the muscimol solution was removed and replaced with formalin

280 ther focal RF infusions of the GABAA agonist muscimol suppressed eating.

281 he resting condition, a dose of baclofen and muscimol that blocked a behaviorally induced increase in

282 Microinjections of glutamate and muscimol to activate or inhibit neuronal cell bodies in

283 SC of four macaques with the GABA(A) agonist muscimol to determine whether this treatment would preve

284 initial training, rats received infusions of muscimol to inactivate the pDMS immediately before sessi

285 f avoidance training, rats were infused with muscimol to pharmacologically inactivate the prelimbic c

286 macaques by intracerebral microinjection of muscimol (to inactivate) or bicuculline (to activate) to

287 striatum was infused with saline or baclofen/muscimol, to temporarily inactivate the region.

288 + neurons in the PF-LHA did not change after muscimol treatments.

289 Picrotoxin or muscimol was applied to the cerebellar cortex at the bor

290 ther saline or 0.005-, 0.05-, 0.5- or 5.0-mM muscimol was delivered through the cup, followed by a 20

291 Furthermore, facilitation of sIPSCs by muscimol was eliminated in a medium containing tetrodoto

292 When muscimol was infused after satiation and therefore, BLA

293 tified, exposure of 1900 or fewer neurons to muscimol was sufficient to sustain whole-body general an

294 Muscimol was used to temporarily inhibit the DHC and was

295 The dose of muscimol we used produces strong contralateral but no ip

296 hypothesis, GABA receptor agonists (baclofen/muscimol) were microinjected into the anterior cingulate

297 hypothalamic injections of small volumes of muscimol, which disrupts normal synaptic functions, befo

298 tal cortex with the GABA(A) receptor agonist muscimol, which eliminates the protective effects of con

299 muL mixture of [(3)H] muscimol and unlabeled muscimol with a final concentration of 1.0mM was deliver

300 rol), the GABA(A) receptor agonist muscimol, muscimol with the GABA(A) receptor antagonist bicucullin